These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34293414)

  • 41. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N; Oberlander TF
    Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Third-party prosocial behavior in adult female rats is impaired after perinatal fluoxetine exposure.
    Heinla I; Heijkoop R; Houwing DJ; Olivier JDA; Snoeren EMS
    Physiol Behav; 2020 Aug; 222():112899. PubMed ID: 32348809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perinatal fluoxetine has enduring sexually differentiated effects on neurobehavioral outcomes related to social behaviors.
    Gemmel M; De Lacalle S; Mort SC; Hill LA; Charlier TD; Pawluski JL
    Neuropharmacology; 2019 Jan; 144():70-81. PubMed ID: 30326241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring.
    Olivier JD; Akerud H; Kaihola H; Pawluski JL; Skalkidou A; Högberg U; Sundström-Poromaa I
    Front Cell Neurosci; 2013; 7():73. PubMed ID: 23734100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developmental exposure to SSRIs, in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity.
    Rayen I; Gemmel M; Pauley G; Steinbusch HW; Pawluski JL
    Psychopharmacology (Berl); 2015 Apr; 232(7):1231-44. PubMed ID: 25304865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure.
    Maloney SE; Akula S; Rieger MA; McCullough KB; Chandler K; Corbett AM; McGowin AE; Dougherty JD
    eNeuro; 2018; 5(4):. PubMed ID: 30073191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
    Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perinatal fluoxetine exposure results in social deficits and reduced monoamine oxidase gene expression in mice.
    Bond CM; Johnson JC; Chaudhary V; McCarthy EM; McWhorter ML; Woehrle NS
    Brain Res; 2020 Jan; 1727():146282. PubMed ID: 31170382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sertraline on central serotonin and hippocampal plasticity in pregnant and non-pregnant rats.
    Pawluski JL; Paravatou R; Even A; Cobraiville G; Fillet M; Kokras N; Dalla C; Charlier TD
    Neuropharmacology; 2020 Apr; 166():107950. PubMed ID: 31935392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
    Ames JL; Ladd-Acosta C; Fallin MD; Qian Y; Schieve LA; DiGuiseppi C; Lee LC; Kasten EP; Zhou G; Pinto-Martin J; Howerton EM; Eaton CL; Croen LA
    Biol Psychiatry; 2021 Aug; 90(4):253-262. PubMed ID: 34116791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats.
    De Long NE; Barry EJ; Pinelli C; Wood GA; Hardy DB; Morrison KM; Taylor VH; Gerstein HC; Holloway AC
    Toxicol Appl Pharmacol; 2015 May; 285(1):32-40. PubMed ID: 25771129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice.
    Yu W; Yen YC; Lee YH; Tan S; Xiao Y; Lokman H; Ting AKT; Ganegala H; Kwon T; Ho WK; Je HS
    Mol Brain; 2019 Apr; 12(1):29. PubMed ID: 30935412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neonatal infant EEG bursts are altered by prenatal maternal depression and serotonin selective reuptake inhibitor use.
    Grieve PG; Fifer WP; Cousy NP; Monk CE; Stark RI; Gingrich JA; Myers MM
    Clin Neurophysiol; 2019 Nov; 130(11):2019-2025. PubMed ID: 31539768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perinatal maternal stress and serotonin signaling: effects on pain sensitivity in offspring.
    Knaepen L; Pawluski JL; Patijn J; van Kleef M; Tibboel D; Joosten EA
    Dev Psychobiol; 2014 Jul; 56(5):885-96. PubMed ID: 24311362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.
    Glazova NY; Manchenko DM; Volodina MA; Merchieva SA; Andreeva LA; Kudrin VS; Myasoedov NF; Levitskaya NG
    Neuropeptides; 2021 Apr; 86():102114. PubMed ID: 33418449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.